A Single Arm Phase II Trial of Circulating Tumor DNA-guided Adjuvant Therapy With Elacestrant in Adults With Hormone Receptor Positive HER2 Negative Breast Cancers at Risk for Late Recurrence (CATE)

16801TBCRC068-NCT06923527OpenA Single Arm Phase II Trial of Circulating Tumor DNA-guided Adjuvant Therapy With Elacestrant in Adults With Hormone Receptor Positive HER2 Negative Breast Cancers at Risk for Late Recurrence (CATE)2000039112NCT06923527OtherAdultTreatmentIIOtherKhoury, KatiaGeorgetown University Medical Center : Alan Zwart; Lombardi Comprehensive Cancer Center : Alan Zwart; Medstar Washington Hospital CenterBreastOncology GroupLombardi Comprehensive Cancer Center (LCCC)16795Alan ZwartAlan Zwartaz6@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>